NEW YORK, Aug. 18, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Global Genetic Testing Market Analysis
http://www.reportlinker.com/p0588171/Global-Genetic-Testing-Market-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genomics
In a rapidly growing molecular diagnostics market, genetic testing represents a highly attractive segment. Genetic testing is a form of medical test that recognizes alteration in chromosomes, genes, or proteins. Most of the time, testing is used to find changes that are associated with inherited disorders. The results of a genetic test can confirm or rule out a suspected genetic condition or help determine a person's chance of developing or passing on a genetic disorder. Several hundred genetic tests are currently in use, and more are being developed.
With the significant increase in the number of available tests, the genetic testing market is witnessing a strong growth pattern. According to our latest report, "Global Genetic Testing Market Analysis", the global genetic testing sector was worth around US$ 1.5 Billion in 2010 that corresponds to a share of approximately 15% in the total molecular diagnostics market. The market is further likely to grow at the rate of around 26% during 2012-2015 to reach around US$ 4 Billion. Factors contributing to this growth include increasing demand of newborn screening, high incidences of Alzheimer disease, breast cancer, colorectal cancer, diabetes etc, and research innovations.
Controversies over the splendid growth of DTC genetic testing have attracted lots of opinions and views on the selling of DNA-based tests directly to consumers. With the FDA intervention, the subject has become of more significance and it would be interesting to see whether new regulations do come in or not. The report, in this context, has presented an effective insight on the current developments in DTC genetic tests.
The report "Global Genetic Testing Market Analysis", covers almost all aspects of the global genetic testing market and provides reliable statistics on current market size and other areas. The report focuses on key regions to illustrate the state of genetic testing market & developments as these countries are witnessing improved private sector activities. Moreover, the availability of gene tests for key diseases has been discussed in a prudent manner. Recent developments with respect to product launches and strategic acquisitions have also been covered. Overall, the report is meant to provide a worth insight into the genetic testing market that would help the client to get acquainted with all the necessary information.
1. Analyst View
2. Research Methodology
3. Introduction to Genetic Testing
4. Global Genetic Testing Market Overview
4.1 Market Outlook
4.2 DTC Genetic Testing
5. Disease Wise Analysis
5.1 Alzheimer's Disease
5.2 Cystic Fibrosis
5.3 Cancer
6. Country Level Analysis
6.1 US
6.2 Europe
6.3 Japan
6.4 Korea
7. Industry Developments
7.1 Key Product Launches
7.2 Key Strategic Acquisitions & Agreements
8. Regulatory Landscape
9. Competitive Assessment
9.1 Abbott Laboratories
9.2 Qiagen N.V.
9.3 bioMerieux SA
9.4 Hoffmann-La Roche Ltd
9.5 Quest Diagnostics
9.6 Myriad Genetics
List of Figures:
Figure 4-1: Molecular Diagnostics Market (Billion US$), 2008-2011
Figure 4-2: Genetic Testing Market (Billion US$), 2008-2011
Figure 4-3: Forecast for Molecular Diagnostics Market (Billion US$), 2012-2015
Figure 4-4: Forecast for Genetic Testing Market (Billion US$), 2012-2015
Figure 4-5: Number of Companies in Biochemical DTC Genetic Testing Segment (2007-2010)
Figure 4-6: Number of DTC Genetic Testing Companies by Country
Figure 6-1: Number of Laboratories and Diseases for Genetic Testing (1993-2010)
Figure 6-2: US - Share of Diagnostics Testing in Healthcare Spending
Figure 6-3: Europe - EQA Scheme Participation by Country (Number), 2010
Figure 9-1: Quest Diagnostics - Sales by Testing (%), 2010
Figure 9-2: Myriad Genetics - Sales by Products (%), 2011
List of Tables:
Table 4-1: Key Companies in DTC Genetic Testing Segment
Table 5-1: Test Availability and Market Size for Key Conditions (2008)
Table 6-1: US - FDA Approved Pharmacogenetic Tests
Table 6-2: EU - Key Indicators in Genetics Market
Table 6-3: Europe - Recognized Accreditation Bodies in Key Countries
Table 8-1: US - Key Elements for Genetic Testing Regulation
Table 8-2: EU - Genetic Testing Regulation in Key Countries
To order this report:
Genomics Industry: Global Genetic Testing Market Analysis
Genomics Business News
Check our Company Profile, SWOT and Revenue Analysis!
CONTACT:
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article